The Biotech Growth Trust Plc - Company Profile
Powered by 
All the sales intelligence you need on The Biotech Growth Trust Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how The Biotech Growth Trust Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with The Biotech Growth Trust Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
The Biotech Growth Trust Plc (BGTP) is an investment fund management company that invests in the biotechnology sector. As of March 31, 2025, it had invested 98.7% of its portfolio in quoted equities, 0.6% in unquoted equities, 0.4% in partnership interest (unquoted) and 0.3% in (Derivatives) OTC equity swaps. The company’s top five contributors to net asset value performance include Gilead Sciences, Argenx SE, CytomX Therapeutics, Intra-Cellular Therapeutics and Morphic Holding. Its investment policy is to seek capital appreciation through its investment in biotechnology companies through OrbiMed Capital LLC (OrbiMed), its portfolio manager, under Frostrow Capital LLP (Frostrow), an alternative investment fund manager, J.P. Morgan Europe Limited as a depositary and J.P. Morgan Securities LLC as its custodian and prime broker.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer